NCT06627517View on ClinicalTrials.gov

Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Type 1 Diabetes MellitusSleep Quality
Interventions
DEVICE

Episodic overnight patch pump

Subjects will wear the study device overnight for a period of 13 weeks in conjunction with use of Dexcom G6.

Trial Locations (3)

55416

International Diabetes Center, Minneapolis

80045

Barbara Davis Center for Diabetes, Aurora

94598

Diablo Clinical Research, Walnut Creek

Sponsors

Lead Sponsor

Luna Diabetes
All Listed Sponsors
lead

Luna Diabetes

INDUSTRY